Link here.
Now, with a 29-day handle.
Locator: 10001H2. This is where hydrogen is tracked. Updates since the original post:
GM, which owns about 80% of Cruise, told Barron’s earlier this month it was finishing production of a small number of commercial Cruise vehicles and then planned to pause production temporarily.
Cruise is still important for GM, which projected the robotaxi company could generate $50 billion in annual sales by 2030. That forecast hasn’t been updated in recent months.
General Motors' Cruise driverless-car unit plans to eventually reintroduce its robotaxi service following safety mishaps, but will narrow the focus to one city and shelve plans for the Origin, a GM-built driverless taxi. Cruise’s new co-president, Mo Elshenawy, outlined in an employee email Wednesday the plan to scale back future operations to one market, a change from an earlier strategy to deploy service in more than a dozen cities, according to people familiar with the matter. Cruise previously had launched efforts in several cities including San Francisco, Phoenix, Austin, Houston and Miami. Elshenawy didn’t cite a timeline to resume service or specify the city, the people said.
Can you find any good news in this story?
In a statement, Cruise confirmed plans to narrow its focus, and said the Origin would be part of its longer-term plans.
“Our strategy is to re-launch in one city and prove our performance there, before expanding,” it said.
The new plans come nearly a month after California regulators revoked Cruise’s driverless permits following an incident in which a self-driving Cruise vehicle hit a pedestrian and dragged her nearly 20 feet. Cruise then chose to suspend operations nationwide.
Since then, Cruise’s board has hired a law firm to investigate Cruise’s response to the incident, and its chief executive, Kyle Vogt, resigned.
If Cruise chooses San Francisco as its singular market, it would need to re-apply for the operational permits it lost. In the email Wednesday, [the new guy] Elshenawy said the Origin would factor into the company’s long-range plans, but near-term service would continue to use retrofitted Chevrolet Bolts, which the company has been using for years.
Nvidia NVDA ’s earnings were impressive but still not enough to push the stock higher. [Comment: incorrect analysis.]
However, the company did enough to show that rivals such as Advanced Micro Devices and Intel have a long way to go to catch up with regard to artificial-intelligence chips.
Nvidia executives didn’t quite dismiss the competition in the earnings call following its October-quarter results, but they stressed their position as the largest player for AI chips.
Their key to maintaining that looks to be a faster pace of technology development, with new releases now set to come every year instead of every two years.
“There is a fundamental reason why we accelerate our execution…because it fundamentally drives down cost,” said Chief Executive Jensen Huang on the call.
More from the link:That pace could be hard for AMD and Intel to match. Nvidia is set to maintain a market share of more than 85% in generative AI accelerator chips next year, according to Raymond James analyst Srini
Pajjuri noted that some customers might pause their spending with Nvidia to wait for the new B100 chips, set for mass production in the second half of next year.
However, that also means customers might hold off on buying AMD’s MI300 AI chip in the meantime, or Intel’s Gaudi 3, which is due next year.
Nvidia’s data center revenue is now projected to hit $65 billion in the fiscal year ending January 2025, more than double the projected combined data-center sales of Intel and AMD for about the same period.
“Despite a growing list of competitors, Nvidia remains the place to train one’s generative AI algorithms largely as a result of the CUDA [software] platform that Nvidia has spent almost 20 years building,” wrote independent analyst Richard Windsor, who publishes Radio Free Mobile.
My hunch: a year from now, some of us will have gone from the “magnificent seven” to the “fantastic four” : AAPL, TSM. NVDA, and ASML.